⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6478607 | 0.64 | — | — | |
| SCHEMBL111375 | 0.62 | — | — | |
| SCHEMBL228107 | 0.62 | — | — | |
| SCHEMBL10566014 | 0.59 | — | — | |
| SCHEMBL706513 | 0.59 | — | — | |
| SCHEMBL847 | 0.59 | — | — | |
| SCHEMBL130150 | 0.59 | — | — | |
| SCHEMBL600739 | 0.59 | — | — | |
| Phosphine SCHEMBL11421364 | 0.59 | — | — | |
| SCHEMBL22775 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0881205-A1 | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1998-12-02 | — | — | EP | claimed |
| US-5633411-A | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1997-05-27 | — | — | US | claimed |
| JP-10330303-A | — | — | None | — | — | JP | disclosed |
| EP-4377311-A1 | 2-DIAZO-3-OXO-2,3-DIHYDROSPIRO[INDENE-1,9'-XANTHENE] DERIVATIVES AND SIMILAR COMPOUNDS AS PHOTOACTIVE FLUORESCENT COMPOUNDS FOR PROTEIN LABELING | Eikon Therapeutics Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| US-11981703-B2 | Polynucleotide constructs | SIRIUS THERAPEUTICS, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| US-20230321083-A1 | Inhibitors of GPR174 and Uses Thereof | OMEROS CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230285556-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION | 2023-09-14 | — | — | US | disclosed |
| US-20230242567-A1 | CHIRAL PHOSPHORAMIDITE AUXILIARIES AND METHODS OF THEIR USE | SIRIUS THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230181493-A1 | BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME | SENDA BIOSCIENCES INC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230086732-A1 | PHOTOACTIVE FLUORESCENT COMPOUNDS AND USE THEREOF FOR LABELING OF PROTEINS | EIKON THERAPEUTICS INC (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2023039578-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION (US) | 2023-03-16 | — | — | WO | disclosed |
| WO-2001036395-A1 | TRIAZOLES AS FARNESYL TRANSFERASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-05-25 | — | — | WO | disclosed |
| JP-H10330303-A | SYNTHESIS OF ALLYL STYRENE ETHER COMPOUND | LOCTITE CORP | 1998-12-15 | — | — | JP | disclosed |
| EP-0881205-A1 | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0881205-A1 | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1998-12-02 | — | — | EP | disclosed |
| US-5633411-A | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5633411-A | Method for production of allyloxystyrene compounds | LOCTITE CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| EP-0332387-B1 | Triazole derivatives, their preparation and their use as fungicides | SANKYO CO (JP) | 1993-11-24 | — | — | EP | disclosed |
| EP-0332387-A1 | Triazole derivatives, their preparation and their use as fungicides | Sankyo Company Limited (JP) | 1989-09-13 | — | — | EP | disclosed |
| US-4777180-A | PARASITICIDES, NEMATOCIDES, MITICIDES | Uclaf, Roussel (FR) | 1988-10-11 | — | — | US | disclosed |